IVA
Closed
Inventiva Sa
2.98
-0.21 (-6.58%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.19
Day's Range: 2.98 - 3.09
Send
sign up or login to leave a comment!
When Written:
3.54
Inventiva SA is a biopharmaceutical company based in France that focuses on the development of small molecule therapies for the treatment of fibrotic diseases, rare diseases, and oncology. The company was founded in 2002 and has since developed a pipeline of drug candidates that target various diseases including non-alcoholic steatohepatitis (NASH), systemic sclerosis, and mucopolysaccharidosis type VI (MPS VI). Inventiva's lead drug candidate, lanifibranor, is being developed for the treatment of NASH and is currently in Phase III clinical trials. The company is also developing a drug candidate for the treatment of systemic sclerosis, called odiparcil, which is in Phase II clinical trials. Inventiva is publicly traded on the Euronext Paris exchange under the symbol IVA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








